Literature DB >> 22117610

NLRP1, a regulator of innate immunity associated with vitiligo.

Andrea D'Osualdo1, John C Reed.   

Abstract

Some familial forms of the dermatological condition vitiligo have recently been linked to polymorphisms in the innate immunity gene, NLRP1. Here, we review what is currently known about the mechanisms that regulate activation of the NLRP1 protein and the downstream effects of NLRP1 on pathways impacting inflammation and apoptosis. How polymorphic variants of the NLRP1 gene contribute to the pathogenesis of vitiligo remains mysterious, requiring further investigation.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22117610     DOI: 10.1111/j.1755-148X.2011.00942.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  9 in total

1.  Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy.

Authors:  S Bank; P S Andersen; J Burisch; N Pedersen; S Roug; J Galsgaard; S Y Turino; J B Brodersen; S Rashid; B K Rasmussen; S Avlund; T B Olesen; H J Hoffmann; B A Nexø; J Sode; U Vogel; V Andersen
Journal:  Pharmacogenomics J       Date:  2017-01-31       Impact factor: 3.550

Review 2.  Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.

Authors:  Juan Pablo de Rivero Vaccari; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-08       Impact factor: 6.200

Review 3.  Inflammasomes and Childhood Autoimmune Diseases: A Review of Current Knowledge.

Authors:  Chin-An Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-25       Impact factor: 8.667

4.  Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress.

Authors:  Weiming Ouyang; Chikako Torigoe; Hui Fang; Tao Xie; David M Frucht
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

5.  Whole exome sequencing identifies a mutation for a novel form of corneal intraepithelial dyskeratosis.

Authors:  Vincent José Soler; Khanh-Nhat Tran-Viet; Stéphane D Galiacy; Vachiranee Limviphuvadh; Thomas Patrick Klemm; Elizabeth St Germain; Pierre R Fournié; Céline Guillaud; Sebastian Maurer-Stroh; Felicia Hawthorne; Cyrielle Suarez; Bernadette Kantelip; Natalie A Afshari; Isabelle Creveaux; Xiaoyan Luo; Weihua Meng; Patrick Calvas; Myriam Cassagne; Jean-Louis Arné; Steven G Rozen; François Malecaze; Terri L Young
Journal:  J Med Genet       Date:  2013-01-24       Impact factor: 6.318

6.  The CARD plays a critical role in ASC foci formation and inflammasome signalling.

Authors:  Martina Proell; Motti Gerlic; Peter D Mace; John C Reed; Stefan J Riedl
Journal:  Biochem J       Date:  2013-02-01       Impact factor: 3.857

7.  A vertebrate adaptive radiation is assembled from an ancient and disjunct spatiotemporal landscape.

Authors:  Emilie J Richards; Joseph A McGirr; Jeremy R Wang; Michelle E St John; Jelmer W Poelstra; Maria J Solano; Delaney C O'Connell; Bruce J Turner; Christopher H Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-18       Impact factor: 11.205

8.  Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.

Authors:  Steffen Bank; Paal Skytt Andersen; Johan Burisch; Natalia Pedersen; Stine Roug; Julied Galsgaard; Stine Ydegaard Turino; Jacob Broder Brodersen; Shaista Rashid; Britt Kaiser Rasmussen; Sara Avlund; Thomas Bastholm Olesen; Hans Jürgen Hoffmann; Bjørn Andersen Nexø; Jacob Sode; Ulla Vogel; Vibeke Andersen
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  Meta-analysis of the association between NLRP1 polymorphisms and the susceptibility to vitiligo and associated autoimmune diseases.

Authors:  Juan Li; Min Yan; Yuan Zhang; Chao Feng; Huicong Wang; Cuiyu Wang; Li Sun
Journal:  Oncotarget       Date:  2017-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.